|
1
|
Barata PC and Rini BI: Treatment of renal
cell carcinoma: Current status and future directions. CA Cancer J
Clin. 67:507–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choueiri TK and Motzer RJ: Systemic
therapy for metastatic renal-cell carcinoma. N Engl J Med.
376:354–366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garcia JA and Rini BI: Recent progress in
the management of advanced renal cell carcinoma. CA Cancer J Clin.
57:112–125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jonasch E, Gao J and Rathmell WK: Renal
cell carcinoma. BMJ. 349:g47972014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long non-coding RNA in the pathogenesis of cancers. Cells.
8:10152019. View Article : Google Scholar
|
|
6
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhan Y, Chen Z, Li Y, He A, He S, Gong Y,
Li X and Zhou L: Long non-coding RNA DANCR promotes malignant
phenotypes of bladder cancer cells by modulating the miR-149/MSI2
axis as a ceRNA. J Exp Clin Cancer Res. 37:2732018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen DL, Lu YX, Zhang JX, Wei XL, Wang F,
Zeng ZL, Pan ZZ, Yuan YF, Wang FH, Pelicano H, et al: Long
non-coding RNA UICLM promotes colorectal cancer liver metastasis by
acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Theranostics. 7:4836–4849. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong Q, Li O, Zheng W, Xiao WZ, Zhang L,
Wu D, Cai GY, He JC and Chen XM: LncRNA HOTAIR regulates HIF-1α/AXL
signaling through inhibition of miR-217 in renal cell carcinoma.
Cell Death Dis. 8:e27722017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li
LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates
breast cancer cell plasticity during EMT and MET plasticity by
differentially sponging miR-200b/c and let-7b. Sci Signal.
10:eaak95572017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Trimarchi T, Bilal E, Ntziachristos P,
Fabbri G, Dalla-Favera R, Tsirigos A and Aifantis I: Genome-wide
mapping and characterization of Notch-regulated long noncoding RNAs
in acute leukemia. Cell. 158:593–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Atianand MK, Hu W, Satpathy AT, Shen Y,
Ricci EP, Alvarez-Dominguez JR, Bhatta A, Schattgen SA, McGowan JD,
Blin J, et al: A long noncoding RNA lincRNA-EPS acts as a
transcriptional brake to restrain inflammation. Cell.
165:1672–1685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tamang S, Acharya V, Roy D, Sharma R,
Aryaa A, Sharma U, Khandelwal A, Prakash H, Vasquez KM and Jain A:
SNHG12: An LncRNA as a potential therapeutic target and biomarker
for human cancer. Front Oncol. 9:9012019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin XJ, Chen XJ, Zhang ZF, Hu WS, Ou RY,
Li S, Xue JS, Chen LL, Hu Y and Zhu H: Long noncoding RNA SNHG12
promotes the progression of cervical cancer via modulating
miR-125b/STAT3 axis. J Cell Physiol. 234:6624–6632. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong J, Wang Q, Li L and Xiao-Jin Z:
Upregulation of long non-coding RNA small nucleolar RNA host gene
12 contributes to cell growth and invasion in cervical cancer by
acting as a sponge for MiR-424-5p. Cell Physiol Biochem.
45:2086–2094. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang B, Hailong S, Yuan J, Zhao H, Xia W,
Zha Z, Bin W and Liu Z: Identification of oncogenic long noncoding
RNA SNHG12 and DUXAP8 in human bladder cancer through a
comprehensive profiling analysis. Biomed Pharmacother. 108:500–507.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou B, Li L, Li Y, Sun H and Zeng C: Long
noncoding RNA SNHG12 mediates doxorubicin resistance of
osteosarcoma via miR-320a/MCL1 axis. Biomed Pharmacother.
106:850–857. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Liu J, Chu L, Yang W, Liu H, Li C
and Yang J: Long noncoding RNA SNHG12 facilitates the tumorigenesis
of glioma through miR-101-3p/FOXP1 axis. Gene. 676:315–321. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Q, Zhou W, Du SQ, Gong DX, Li J, Bi
JB, Li ZH, Zhang Z, Li ZL, Liu XK and Kong CZ: Overexpression of
SNHG12 regulates the viability and invasion of renal cell carcinoma
cells through modulation of HIF1α. Cancer Cell Int. 19:1282019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C,
Wang J, Tan Q, Cheng Y, Xia E, et al: C-MYC-induced upregulation of
lncRNA SNHG12 regulates cell proliferation, apoptosis and migration
in triple-negative breast cancer. Am J Transl Res. 9:533–545.
2017.PubMed/NCBI
|
|
22
|
Liu ZB, Tang C, Jin X, Liu SH and Pi W:
Increased expression of lncRNA SNHG12 predicts a poor prognosis of
nasopharyngeal carcinoma and regulates cell proliferation and
metastasis by modulating Notch signal pathway. Cancer Biomark.
23:603–613. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xian HP, Zhuo ZL, Sun YJ, Liang B and Zhao
XT: Circulating long non-coding RNAs HULC and ZNFX1-AS1 are
potential biomarkers in patients with gastric cancer. Oncol Lett.
16:4689–4698. 2018.PubMed/NCBI
|
|
24
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part a: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:313–326.e315. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boguslawska J, Kedzierska H, Poplawski P,
Rybicka B, Tanski Z and Piekielko-Witkowska A: Expression of genes
involved in cellular adhesion and extracellular matrix remodeling
correlates with poor survival of patients with renal cancer. J
Urol. 195:1892–1902. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yarani R, Mirza AH, Kaur S and Pociot F:
The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol
Med. 50:1–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lan T, Ma W, Hong Z, Wu L, Chen X and Yuan
Y: Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12)
promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in
hepatocellular carcinoma. J Exp Clin Cancer Res. 36:112017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding S, Qu W, Jiao Y, Zhang J, Zhang C and
Dang S: LncRNA SNHG12 promotes the proliferation and metastasis of
papillary thyroid carcinoma cells through regulating wnt/β-catenin
signaling pathway. Cancer Biomark. 22:217–226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang P, Chen D, Ma H and Li Y: LncRNA
SNHG12 contributes to multidrug resistance through activating the
MAPK/Slug pathway by sponging miR-181a in non-small cell lung
cancer. Oncotarget. 8:84086–84101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maolakuerban N, Azhati B, Tusong H, Abula
A, Yasheng A and Xireyazidan A: MiR-200c-3p inhibits cell migration
and invasion of clear cell renal cell carcinoma via regulating
SLC6A1. Cancer Biol Ther. 19:282–291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang J, Yi BO, Ding S, Sun J, Cao W and
Liu M: Demethylation drug 5-Aza-2′-deoxycytidine-induced
upregulation of miR-200c inhibits the migration, invasion and
epithelial-mesenchymal transition of clear cell renal cell
carcinoma in vitro. Oncol Lett. 11:3167–3172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang X, Chen X, Han W, Ruan A, Chen L,
Wang R, Xu Z, Xiao P, Lu X, Zhao Y, et al: miR-200c targets CDK2
and suppresses tumorigenesis in renal cell carcinoma. Mol Cancer
Res. 13:1567–1577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao C, Peng FH and Peng LK: MiR-200c
sensitizes clear-cell renal cell carcinoma cells to sorafenib and
imatinib by targeting heme oxygenase-1. Neoplasma. 61:680–689.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou
Z, Chang C, Qi J and Yeh S: Estrogen receptor β promotes renal cell
carcinoma progression via regulating LncRNA
HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene.
37:5037–5053. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ying G, Wu R, Xia M, Fei X, He QE, Zha C
and Wu F: Identification of eight key miRNAs associated with renal
cell carcinoma: A meta-analysis. Oncol Lett. 16:5847–5855.
2018.PubMed/NCBI
|
|
42
|
Wu YH, Chang TH, Huang YF, Chen CC and
Chou CY: COL11A1 confers chemoresistance on ovarian cancer cells
through the activation of Akt/c/EBPβ pathway and PDK1
stabilization. Oncotarget. 6:23748–23763. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu YH, Chang TH, Huang YF, Huang HD and
Chou CY: COL11A1 promotes tumor progression and predicts poor
clinical outcome in ovarian cancer. Oncogene. 33:3432–3440. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jia D, Liu Z, Deng N, Tan TZ, Huang RY,
Taylor-Harding B, Cheon DJ, Lawrenson K, Wiedemeyer WR, Walts AE,
et al: A COL11A1-correlated pan-cancer gene signature of activated
fibroblasts for the prioritization of therapeutic targets. Cancer
Lett. 382:203–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang H, Wu J, Zhang J, Yang Z, Jin W, Li
Y, Jin L, Yin L, Liu H and Wang Z: Integrated bioinformatics
analysis of key genes involved in progress of colon cancer. Mol
Genet Genomic Med. 7:e005882019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Feldmann G, Habbe N, Dhara S, Bisht S,
Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy
N, et al: Hedgehog inhibition prolongs survival in a genetically
engineered mouse model of pancreatic cancer. Gut. 57:1420–1430.
2008. View Article : Google Scholar : PubMed/NCBI
|
